Inventor · disambiguated record
Mark Wade Moore
Also filed as: MOORE MARK W · MOORE MARK WADE
9 granted patents·3 pending applications·41 citations·filing 1995–2019
84Inventor score
Top patents by PatentIndex Score
12 records- 0175US9918997B2Compositions and methods for the treatment of neurodegenerative and other diseasesREEDER THADDEUS CROMWELL·Filed 2017·Granted Mar 20, 2018·1 cites·11 claims
- 0274US7691606B2Polynucleotides encoding GDNFRαGENENTECH INC·Filed 2006·Granted Apr 6, 2010·1 cites·10 claims
- 0370US5874080AAnti-IL-8 monoclonal antibodies for treatment of asthmaGENENTECH INC·Filed 1995·Granted Feb 23, 1999·34 cites·13 claims
- 0469US7105484B2GDNF receptorαGENENTECH INC·Filed 2001·Granted Sep 12, 2006·3 cites·11 claims
- 0564US9980978B2Compositions and methods for the treatment of neurodegenerative and other diseasesGLIALOGIX INC·Filed 2016·Granted May 29, 2018·0 cites·3 claims
- 0664US9974798B2Compositions and methods for the treatment of neurodegenerative and other diseasesGLIALOGIX INC·Filed 2016·Granted May 22, 2018·0 cites·8 claims
- 0764US2010313283A1Uses of gdnf and gdnf receptorKLEIN ROBERT D·Filed 2009·Application pending·0 cites
- 0863US10398713B2Compositions and methods for the treatment of neurodegenerative and other diseasesGLIALOGIX INC·Filed 2018·Granted Sep 3, 2019·0 cites·11 claims
- 0961US9597339B2Compositions and methods for the treatment of neurodegenerative and other diseasesGLIALOGIX INC·Filed 2014·Granted Mar 21, 2017·0 cites·4 claims
- 1056US2020009118A1Compositions and methods for the treatmentof neurodegenerative and other diseasesGLIALOGIX INC·Filed 2019·Application pending·0 cites
- 1149US2018110760A1Compositions and methods for the treatmentof neurodegenerative and other diseasesGLIALOGIX INC·Filed 2017·Application pending·0 cites
- 1239US6504007B1GDNF receptorGENENTECH INC·Filed 1997·Granted Jan 7, 2003·2 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Mark Wade Moore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →